NowPatient Review

Best for: early adopters who want Foundayo via a one-stop telehealth platform

Telehealth platform offering Foundayo (orforglipron) prescriptions via online clinician consultation. Confirmed as a Foundayo channel via Endocrine News coverage of the April 2026 rollout. Pricing tier and full state availability TBD as the rollout matures.

7.1
★★★3.6
FoundayoTelehealthBrand Name

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

The Bottom Line

NowPatient is a solid telehealth option with balanced features and pricing.

Score: 7.1/10Best for: early adopters who want Foundayo via a one-stop telehealth platformFrom: $199/mo

Score Breakdown

Value
7
Effectiveness
7.5
User Experience
7
Trust & Safety
7
Accessibility
7
Support
7

Pricing

DoseFormPrice/mo
Foundayo (consult + drug, pricing TBD)brand$199

Pros

  • Confirmed early Foundayo channel (April 2026 rollout)
  • Daily oral pill — no needles, no refrigeration
  • Telehealth consultation included

Cons

  • Pricing tier not yet publicly verified — confirm directly with the provider
  • State-by-state availability still being phased in
  • Lower mean weight loss vs injectable GLP-1s (~11.1% vs 14.9% Wegovy and 20.9% Zepbound at labeled max)

Ready to start with NowPatient?

Starting at $199/month. See current pricing and start your free consultation.

Sources & methodology

Our NowPatient review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.

Sources & methodology — as of April 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy FrameworkU.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board StandardsAccreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)Kaiser Family Foundation.

Alternatives to NowPatient

7.7/ 10

Alan Meds

Best for: budget-conscious shoppers

★★★3.9

Editorial score · methodology

$99/mo
CompoundedSemaglutideTirzepatideOral Format
Get Started
7.5/ 10

Amazing Meds

Best for: patients seeking compounded retatrutide access (with eyes open about regulatory status)

★★★3.8

Editorial score · methodology

$199/mo
CompoundedSemaglutideTirzepatideRetatrutide
Get Started
7.7/ 10

AmberHealth

Best for: budget-conscious shoppers

★★★3.9

Editorial score · methodology

$100/mo
CompoundedSemaglutideTirzepatide
Get Started

Frequently Asked Questions

Ready to start with NowPatient?

Starting at $199/month. See current pricing and start your free consultation.